Topical Clonidine（神経因性疼痛）：医薬品市場予測及び分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 11
3 Disease Overview 13
3.1 Clinical Manifestations of Neuropathic Pain – Signs and Symptoms 15
3.1.1 Painful Diabetic Neuropathy 17
3.1.2 Postherpetic Neuralgia 18
3.1.3 Trigeminal Neuralgia 18
3.2 Etiology and Pathophysiology 19
3.2.1 Etiology 20
3.2.2 Pathophysiology 21
4 Disease Management 29
4.1 Diagnosis and Treatment Overview 29
4.1.1 Diagnosis 29
4.1.2 Treatment Overview and Guidelines 36
5 Competitive Assessment 46
5.1 Overview 46
6 Unmet Need and Opportunity 51
6.1 Overview 51
6.2 Physician Knowledge or Awareness 52
6.2.1 Unmet Need 52
6.2.2 Gap Analysis 53
6.2.3 Opportunity 54
6.3 Diagnostic Challenges 54
6.3.1 Unmet Need 54
6.3.2 Gap Analysis 55
6.3.3 Opportunity 55
6.4 Low Treatment Rate and Underdosing of Medications 55
6.4.1 Unmet Need 55
6.4.2 Gap Analysis 57
6.4.3 Opportunity 57
6.5 Unsatisfactory Efficacy and Safety Profiles of Pharmacological Treatments 58
6.5.1 Unmet Need 58
6.5.2 Gap Analysis 59
6.5.3 Opportunity 59
6.6 Elderly Patient Population – Drug Tolerability 60
6.6.1 Unmet Need 60
6.6.2 Gap Analysis 60
6.6.3 Opportunity 61
6.7 Rational or Personalized Therapies 61
6.7.1 Unmet Need 61
6.7.2 Gap Analysis 62
6.7.3 Opportunity 62
7 Pipeline Assessment 64
7.1 Overview 64
7.2 Promising Drugs in Clinical Development 65
8 Topical Clonidine Gel 68
8.1 Overview 68
8.2 Efficacy 69
8.3 Safety 70
8.4 Dosing and Formulation 70
8.5 Potential Clinical and Commercial Positioning 70
8.6 Pricing and Reimbursement 70
8.7 SWOT Analysis 71
8.8 Forecast 71
9 Appendix 73
9.1 Bibliography 73
9.2 Abbreviations 77
9.3 Methodology 81
9.4 Forecasting Methodology 81
9.4.1 Diagnosed PDN, PHN, and TN Patients 81
9.4.2 Percent Drug-Treated Patients 82
9.4.3 General Pricing Assumptions 82
9.4.4 Generic Erosion 82
9.4.5 Pricing of Pipeline Agents 82
9.5 Physicians and Specialists Included in This Study 83
9.6 About the Authors 85
9.6.1 Author 85
9.6.2 Global Head of Healthcare 86
9.7 About GlobalData 87
9.8 Disclaimer 87